Literature DB >> 8625236

DNA ploidy in nonmelanoma skin cancer.

J K Robinson1, A W Rademaker, C Goolsby, T N Traczyk, C Zoladz.   

Abstract

BACKGROUND: Patients with head and neck squamous cell carcinoma die of locoregional recurrence and those with basal cell carcinoma suffer cosmetic and functional changes from its treatment. Prognostic factors are based upon tumor characteristics and host factors. Flow cytometry can assist with prognostic characterization of nonmelanoma skin cancer.
METHODS: Specimens from 40 sequential patients with head and neck nonmelanoma skin cancers were prospectively obtained at the time of surgery. The patients were followed for four years for local recurrence and metastasis to regional lymph nodes. Samples were prepared from frozen specimens using a modification of the Vindelov procedure.
RESULTS: DNA aneuploidy or tetraploidy and histology of well differentiated squamous cell carcinoma were significantly associated with metastasis to regional lymph nodes. Direct extension of tumor below the adipose tissue was associated with an S-phase greater than 4.1 and a proliferative fraction greater than 5.5. No tumors recurred at the site of surgical resection.
CONCLUSIONS: The measurement of DNA ploidy of well differentiated squamous cell carcinoma, and proliferative capacity or S-phase of both basal cell and squamous cell carcinomas assists in predicting the biologic proclivity for locoregional invasion or metastasis of nonmelanoma skin cancer. Identification of aggressive tumors at the time of surgery may offer the opportunity for prevention of lethal metastasis by using adjunctive therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625236     DOI: 10.1002/(SICI)1097-0142(19960115)77:2<284::AID-CNCR10>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.

Authors:  Evan S Glazer; Peter H Bartels; Anil R Prasad; Michael L Yozwiak; Hubert G Bartels; Janine G Einspahr; David S Alberts; Robert S Krouse
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-02

2.  Karyometry of nuclear phenotypes in cutaneous squamous cell cancer.

Authors:  Peter H Bartels; Hubert G Bartels; David S Alberts; Michael Yozwiak; Anil R Prasad; Evan S Glazer; Robert S Krouse
Journal:  Anal Quant Cytol Histol       Date:  2012-02       Impact factor: 0.302

3.  Chromosomal aberrations in PARP(-/-) mice: genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA.

Authors:  C M Simbulan-Rosenthal; B R Haddad; D S Rosenthal; Z Weaver; A Coleman; R Luo; H M Young; Z Q Wang; T Ried; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes.

Authors:  Elaine M Sloand; Loretta Pfannes; Casey Ling; Xingmin Feng; Monika Jasek; Rodrigo Calado; Zachary C G Tucker; Peiman Hematti; Jaroslaw Maciejewski; Cynthia Dunbar; John Barrett; Neal Young
Journal:  Biol Blood Marrow Transplant       Date:  2010-07-24       Impact factor: 5.742

5.  Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase.

Authors:  C M Simbulan-Rosenthal; D H Ly; D S Rosenthal; G Konopka; R Luo; Z Q Wang; P G Schultz; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R Luo; J H Li; J Zhang; M E Smulson
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

7.  Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells.

Authors:  Sandhya Noronha; Lauren A C Alt; Taylor E Scimeca; Omran Zarou; Justyna Obrzut; Brian Zanotti; Elizabeth A Hayward; Akhil Pillai; Shubha Mathur; Joseph Rojas; Ribhi Salamah; Nalini Chandar; Michael J Fay
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.